Literature DB >> 10968604

Gynecologic conditions and bacterial vaginosis: implications for the non-pregnant patient.

R L Sweet1.   

Abstract

Bacterial vaginosis is characterized by a shift from the predominant lactobacillus vaginal flora to an overgrowth of anaerobic bacteria. Bacterial vaginosis is associated with an increased risk of gynecologic complications, including pelvic inflammatory disease, postoperative infection, cervicitis, human immunodeficiency virus (HIV), and possibly cervical intraepithelial neoplasia (CIN). The obstetrical risks associated with bacterial vaginosis include premature rupture of membranes, preterm labor and delivery, chorioamnionitis and postpartum endometritis. Despite the health risks associated with bacterial vaginosis and its high prevalence in women of childbearing age, bacterial vaginosis continues to be largely ignored by clinicians, particularly in asymptomatic women.

Entities:  

Mesh:

Year:  2000        PMID: 10968604      PMCID: PMC1784684          DOI: 10.1155/S1064744900000260

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  27 in total

1.  Bacterial vaginosis in women attending STD clinic: diagnostic criteria and prevalence of Mobiluncus spp.

Authors:  A Hallén; C Påhlson; U Forsum
Journal:  Genitourin Med       Date:  1987-12

2.  Mobiluncus and clue cells as predictors of PID after first-trimester abortion.

Authors:  P G Larsson; B Bergman; U Forsum; J J Platz-Christensen; C Påhlson
Journal:  Acta Obstet Gynecol Scand       Date:  1989       Impact factor: 3.636

3.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

4.  Bacterial vaginosis as a risk factor for post-cesarean endometritis.

Authors:  D H Watts; M A Krohn; S L Hillier; D A Eschenbach
Journal:  Obstet Gynecol       Date:  1990-01       Impact factor: 7.661

Review 5.  Bacterial vaginosis: current review with indications for asymptomatic therapy.

Authors:  J L Thomason; S M Gelbart; N J Scaglione
Journal:  Am J Obstet Gynecol       Date:  1991-10       Impact factor: 8.661

6.  Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations.

Authors:  R Amsel; P A Totten; C A Spiegel; K C Chen; D Eschenbach; K K Holmes
Journal:  Am J Med       Date:  1983-01       Impact factor: 4.965

7.  Microbiological and histopathological findings in acute pelvic inflammatory disease.

Authors:  J Paavonen; K Teisala; P K Heinonen; R Aine; S Laine; M Lehtinen; A Miettinen; R Punnonen; P Grönroos
Journal:  Br J Obstet Gynaecol       Date:  1987-05

8.  Bacterial vaginosis: microbiological and clinical findings.

Authors:  E Holst; B Wathne; B Hovelius; P A Mårdh
Journal:  Eur J Clin Microbiol       Date:  1987-10       Impact factor: 3.267

9.  Diagnosis and clinical manifestations of bacterial vaginosis.

Authors:  D A Eschenbach; S Hillier; C Critchlow; C Stevens; T DeRouen; K K Holmes
Journal:  Am J Obstet Gynecol       Date:  1988-04       Impact factor: 8.661

10.  Clue cells in predicting infections after abdominal hysterectomy.

Authors:  P G Larsson; J J Platz-Christensen; U Forsum; C Påhlson
Journal:  Obstet Gynecol       Date:  1991-03       Impact factor: 7.661

View more
  32 in total

Review 1.  Bacterial vaginosis: more questions than answers.

Authors:  Erica Weir
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

2.  The vaginal microbiome in health and disease.

Authors:  Bryan A White; Douglas J Creedon; Karen E Nelson; Brenda A Wilson
Journal:  Trends Endocrinol Metab       Date:  2011-07-13       Impact factor: 12.015

3.  Elusive aetiology of bacterial vaginosis. Do lesbians have a clue?

Authors:  Jeanne M Marrazzo
Journal:  Sex Transm Infect       Date:  2007-10       Impact factor: 3.519

Review 4.  Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies.

Authors:  Julius Atashili; Charles Poole; Peter M Ndumbe; Adaora A Adimora; Jennifer S Smith
Journal:  AIDS       Date:  2008-07-31       Impact factor: 4.177

5.  Association between BVAB1 and high Nugent scores among women with bacterial vaginosis.

Authors:  Christina A Muzny; Imran R Sunesara; Michael E Griswold; Ranjit Kumar; Elliot J Lefkowitz; Leandro A Mena; Jane R Schwebke; David H Martin; Edwin Swiatlo
Journal:  Diagn Microbiol Infect Dis       Date:  2014-09-16       Impact factor: 2.803

6.  High Levels of Inflammatory Cytokines in the Reproductive Tract of Women with BV and Engaging in Intravaginal Douching: A Cross-Sectional Study of Participants in the Women Interagency HIV Study.

Authors:  Maria L Alcaide; Violeta J Rodriguez; Megan R Brown; Suresh Pallikkuth; Kristopher Arheart; Octavio Martinez; Margaret Roach; Raina N Fichorova; Deborah L Jones; Savita Pahwa; Margaret A Fischl
Journal:  AIDS Res Hum Retroviruses       Date:  2017-01-03       Impact factor: 2.205

7.  Prevalence of bacterial vaginosis and vaginal flora changes in peri- and postmenopausal women.

Authors:  Sabina Cauci; Silvia Driussi; Davide De Santo; Paola Penacchioni; Teresa Iannicelli; Paolo Lanzafame; Francesco De Seta; Franco Quadrifoglio; Domenico de Aloysio; Secondo Guaschino
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

8.  Prevalence and risks for bacterial vaginosis in women who have sex with women.

Authors:  Jeanne M Marrazzo; Katherine K Thomas; Kathy Agnew; Kathleen Ringwood
Journal:  Sex Transm Dis       Date:  2010-05       Impact factor: 2.830

9.  Sexual practices, risk perception and knowledge of sexually transmitted disease risk among lesbian and bisexual women.

Authors:  Jeanne M Marrazzo; Patricia Coffey; Allison Bingham
Journal:  Perspect Sex Reprod Health       Date:  2005-03

10.  Risks for acquisition of bacterial vaginosis among women who report sex with women: a cohort study.

Authors:  Jeanne M Marrazzo; Katherine K Thomas; Tina L Fiedler; Kathleen Ringwood; David N Fredricks
Journal:  PLoS One       Date:  2010-06-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.